Purpose
to co-fund the clinical development program of Islatravir for HIV prevention, specifically for the IMPOWER phase 3 efficacy and safety trial among women and adolescent girls in sub-Saharan Africa
Grantee
Division
Global Health
Date
MARCH 2021
Region served
GLOBAL
Committed amount
$122,264,513
Grant topic
HIV
Duration (months)
76
Grantee location
Seattle, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.